These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29171759)

  • 21. Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy.
    Quinn RA; Nothias LF; Vining O; Meehan M; Esquenazi E; Dorrestein PC
    Trends Pharmacol Sci; 2017 Feb; 38(2):143-154. PubMed ID: 27842887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development.
    Sobrio F; Gilbert G; Perrio C; Barré L; Debruyne D
    Mini Rev Med Chem; 2010 Aug; 10(9):870-86. PubMed ID: 20504276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.
    Ings RM
    Bioanalysis; 2009 Oct; 1(7):1293-305. PubMed ID: 21083052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution isotope-dilution mass spectrometry using metabolism of isotope-labeled compounds: application to drug metabolites.
    Vrbanac JJ; Hilgers A; Dubnicka T; Shilliday FB; Humphries D; Hayes RN
    Rapid Commun Mass Spectrom; 2012 Nov; 26(22):2569-76. PubMed ID: 23059872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies.
    Gu H; Wang J; Aubry AF; Jiang H; Zeng J; Easter J; Wang JS; Dockens R; Bifano M; Burrell R; Arnold ME
    Anal Chem; 2012 Jun; 84(11):4844-50. PubMed ID: 22540405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.
    Bergström M; Grahnén A; Långström B
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):357-66. PubMed ID: 12937873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of human phase 0 microdosing trials: A systematic review and perspectives.
    Svendsen P; El-Galaly TC; Dybkær K; Bøgsted M; Laursen MB; Schmitz A; Jensen P; Johnsen HE
    Leuk Lymphoma; 2016; 57(6):1281-90. PubMed ID: 26428262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. geoRge: A Computational Tool To Detect the Presence of Stable Isotope Labeling in LC/MS-Based Untargeted Metabolomics.
    Capellades J; Navarro M; Samino S; Garcia-Ramirez M; Hernandez C; Simo R; Vinaixa M; Yanes O
    Anal Chem; 2016 Jan; 88(1):621-8. PubMed ID: 26639619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.
    Brooks DJ
    NeuroRx; 2005 Apr; 2(2):226-36. PubMed ID: 15897947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC-MS-based metabolomics: an update.
    Fang ZZ; Gonzalez FJ
    Arch Toxicol; 2014 Aug; 88(8):1491-502. PubMed ID: 24710571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
    Ray Banerjee S; Chen Z; Pullambhatla M; Lisok A; Chen J; Mease RC; Pomper MG
    Bioconjug Chem; 2016 Jun; 27(6):1447-55. PubMed ID: 27076393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging new strategies for successful metabolite identification in metabolomics.
    Bingol K; Bruschweiler-Li L; Li D; Zhang B; Xie M; Brüschweiler R
    Bioanalysis; 2016 Mar; 8(6):557-73. PubMed ID: 26915807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of mass spectrometry in drug metabolism: 50 years of progress.
    Wen B; Zhu M
    Drug Metab Rev; 2015 Feb; 47(1):71-87. PubMed ID: 25639893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development.
    Burt T; Vuong LT; Baker E; Young GC; McCartt AD; Bergstrom M; Sugiyama Y; Combes R
    Altern Lab Anim; 2018 Dec; 46(6):335-346. PubMed ID: 30657329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-Time Microfluidic Blood-Counting System for PET and SPECT Preclinical Pharmacokinetic Studies.
    Convert L; Lebel R; Gascon S; Fontaine R; Pratte JF; Charette P; Aimez V; Lecomte R
    J Nucl Med; 2016 Sep; 57(9):1460-6. PubMed ID: 27151983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel strategies for microdose studies using non-radiolabeled compounds.
    Maeda K; Sugiyama Y
    Adv Drug Deliv Rev; 2011 Jun; 63(7):532-8. PubMed ID: 21345359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and preliminary in vivo evaluation of well-dispersed biomimetic nanocrystalline apatites labeled with positron emission tomographic imaging agents.
    Sandhöfer B; Meckel M; Delgado-López JM; Patrício T; Tampieri A; Rösch F; Iafisco M
    ACS Appl Mater Interfaces; 2015 May; 7(19):10623-33. PubMed ID: 25915450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography for use in microdosing studies.
    Wagner CC; Müller M; Lappin G; Langer O
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.